COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,036 Articles (22,627 medRxiv, 8,409 bioRxiv)

Most recent first Previous |  Page 594: Articles 5931-5940  | Next

Immune responses of the third dose of AZD1222 vaccine or BNT162b2 mRNA vaccine after two doses of CoronaVac vaccines against Delta and Omicron variants
Niyomnaitham, S., Jongkaewwattana, A., Meesing, A., Chusri, S., Nanthapisal, S., Hirankarn, N., Siwamogsatham, S., Kirdlarp, S., Chaiwarith, R., Lawpoolsri Niyom, S., Thitithanyanont, A., Hansasuta, P., Pornprasit, K., Chaiyaroj, S., Pitisuttithum, P.
10.1101/2022.10.02.22280572 — Posted: 2022-10-03
Reproducibility of spatial summation of pain effect during COVID-19 pandemic
Nastaj, J., Skalski, J., Budzisz, A., Szikszay, T. M., Swoboda, S., Kowalska, W., Nowak, D., Zbroja, E., Kruszyna, N., Jakubinska, M., Grygny, D., Polczyk, R., Malecki, A., Luedtke, K., Adamczyk, W. M.
10.1101/2022.09.30.510274 — Posted: 2022-10-03
Intranasal delivery of NS1-deleted influenza virus vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response
Zhang, L., Jiang, Y., He, J., Chen, J., Qi, R., Yuan, L., Shao, T., Chen, C., Chen, Y., Wang, X., Lei, X., Gao, Q., Zhuang, C., Zhou, M., Ma, J., Liu, W., Yang, M., Fu, R., Wu, Y., Chen, F., Xiong, H., Nie, M., Chen, Y., Wu, K., Fang, M., Wang, Y., Zheng, Z., Huang, S., Ge, S., Cheng, S.-C., Zhu, H., Chen, T., Yuan, Q., Wu, T., Zhang, J., Chen, Y., Zhang, T., Qi, H., Guan, Y., Xia, N.
10.1101/2022.10.03.510566 — Posted: 2022-10-03
CiDRE+ M2c macrophages hijacked by SARS-CoV-2 cause COVID-19 severity
Mitsui, Y., Suzuki, T., Kuniyoshi, K., Inamo, J., Yamaguchi, K., Komuro, M., Watanabe, J., Edamoto, M., Li, S., Kouno, T., Oba, S., Hosoya, T., Koyama, S., Sakaguchi, N., Standley, D. M., Shin, J. W., Akira, S., Yasuda, S., Miyazaki, Y., Kochi, Y., Kumanogoh, A., Okamoto, T., Satoh, T.
10.1101/2022.09.30.510331 — Posted: 2022-10-03
SARS-CoV-2 spike protein induces endothelial dysfunction in 3D engineered vascular networks
Stern, B., Monteleone, P., Zoldan, J.
10.1101/2022.10.01.510442 — Posted: 2022-10-03
Biophysical characterisation of the structure of a SARS-CoV-2 self-amplifying - RNA (saRNA) vaccine
Myatt, D. P., Wharram, L., Graham, C., Liddell, J., Branton, H., Pizzey, C., Cowieson, N., Rambo, R., Shattock, R.
10.1101/2022.10.03.507132 — Posted: 2022-10-03
Reduction in circulating monocytes correlates with persistent post-COVID pulmonary fibrosis in multi-omic comparison of long-haul COVID and IPF
Bingham, G. C., Muehling, L. M., Li, C., Huang, Y., Abebayehu, D., Noth, I., Sun, J., Woodfolk, J. A., Barker, T. H., Bonham, C.
10.1101/2022.09.30.22280468 — Posted: 2022-10-02
COVID treatment and in-hospital length of stay inequalities between race in the US over time
Althouse, B. M., Baker, C., Smits, P. D., Gratzl, S., Lee, R. H., Cartwright, B. M. G., Siminov, M., Wang, M. D., Stucky, N.
10.1101/2022.09.30.22280586 — Posted: 2022-10-01
COVID-19 vaccine antibody response is associated with side-effects, chronic health conditions, and vaccine type in a large Northern California cohort
Solomon, O., Adams, C., Horton, M., Wong, M. P., Meas, M., Shao, X., Fedrigo, I., Hernandez, S., Quach, H. L., Quach, D. L., Barcellos, A. L., Coloma, J., Busch, M. P., Harris, E., Barcellos, L. F.
10.1101/2022.09.30.22280166 — Posted: 2022-10-01
Effectiveness of mRNA-1273 against infection and COVID-19 hospitalization with SARS-CoV-2 Omicron subvariants: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Tseng, H. F., Ackerson, B. K., Bruxvoort, K. J., Sy, L. S., Tubert, J. E., Lee, G. S., Ku, J. H., Florea, A., Luo, Y., Qiu, S., Choi, S. K., Takhar, H. S., Aragones, M., Paila, Y. D., Chavers, S., Qian, L.
10.1101/2022.09.30.22280573 — Posted: 2022-10-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).